tiprankstipranks
Trending News
More News >
Solasia Pharma KK (DE:9SO)
FRANKFURT:9SO
Germany Market

Solasia Pharma KK (9SO) Income Statement

Compare
0 Followers

Solasia Pharma KK Income Statement

Last quarter (Q4 2025), Solasia Pharma KK's total revenue was ¥338.00M, an increase of 43.83% from the same quarter last year. In Q4, Solasia Pharma KK's net income was ¥-150.00M. See Solasia Pharma KK’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 429.00M¥ 316.00M¥ 617.00M¥ 1.09B¥ 559.00M
Gross Profit
¥ 171.00M¥ -10.00M¥ -163.00M¥ 128.00M¥ -121.00M
Operating Expenses
¥ 1.03B¥ 981.00M¥ 976.00M¥ 1.86B¥ 2.30B
Depreciation and Amortization
¥ 37.00M¥ 195.00M¥ 500.00M¥ 534.00M¥ 495.00M
EBITDA
¥ -822.00M¥ -796.00M¥ -639.00M¥ -1.20B¥ -1.92B
Operating Income
¥ -859.00M¥ -991.00M¥ -1.14B¥ -1.73B¥ -2.42B
Other Income/Expenses
¥ -17.00M¥ -970.00M¥ 4.00M¥ -763.00M¥ -23.00M
Pretax Income
¥ -876.00M¥ -1.96B¥ -1.14B¥ -2.49B¥ -2.44B
Net Income
¥ -876.00M¥ -1.94B¥ -1.11B¥ -2.55B¥ -2.48B
Per Share Metrics
Basic EPS
¥ -3.69¥ -9.77¥ -6.61¥ -16.76¥ -19.04
Diluted EPS
¥ -3.69¥ -9.77¥ -6.61¥ -16.76¥ -19.04
Weighted Average Shares Outstanding
237.52M 198.70M 168.13M 151.99M 130.15M
Weighted Average Shares Outstanding (Diluted)
237.52M 198.70M 168.13M 151.99M 130.15M
Currency in JPY

Solasia Pharma KK Earnings and Revenue History